Summary of use during lactation
Tirofiban is an antiplatelet drug given by intravenous infusion. Its oral bioavailability has not been studied in humans, but is only 2.2% in rats. No information is available on the drug’s use during breastfeeding, but infants would not be expected to absorb clinically relevant amounts of the drug from milk. If a mother requires tirofiban, it is not a reason to discontinue breastfeeding, but monitor the infant for bruising or bleeding.
Drug levels in milk and infant serum
Maternal Levels. Relevant published information was not found as of the revision date. Infant Levels. Relevant published information was not found as of the revision date.
Effects in breastfed infants
Relevant published information was not found as of the revision date.
Effects on lactation and breastmilk
Relevant published information was not found as of the revision date.
Source: Drugs and Lactation Database (LactMed®), National Institute of Child Health and Human Development, NCBI Bookshelf. Check LactMed for the most recent revision.
Medical disclaimer: This page is for qualified healthcare professionals and is a decision-support aid only. It does not replace clinical judgement, local protocols or product information. Verify every dose and threshold before use. See the full Medical Disclaimer.